RFK and Alzheimer disease: Moreover, mRNA levels of human RFK (riboflavin kinase), the ortholog of yeast FMN1, have found to be significantly lower in the cerebellum, visual cortex and prefrontal cortex of AD patients versus controls (Fig. 2c).